Local variations in the epidemiology, microbiology, and outcome of necrotizing soft-tissue infections: A multicenter study

American Journal of Surgery

Volumn 202, Issue 2, 2011, Pages 139-145

  Kao, Lillian S ^a   Lew, Debbie F ^a   Arab, Samer N ^a   Todd, S Rob ^b   Awad, Samir S ^c   Carrick, Matthew M ^c   Corneille, Michael G ^d   Lally, Kevin P ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b HOUSTON METHODIST HOSPITAL   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

^d Mays Cancer Center at UT Health San Antonio   (United States)

Author keywords

Methicillin resistant Staphylococcus aureus; Necrotizing fasciitis; Necrotizing soft tissue infections

Indexed keywords

DROTRECOGIN; INSULIN; LINEZOLID; OXYGEN; VANCOMYCIN;

ADULT; AGED; AMPUTATION; ANAEROBIC BACTERIUM; ARTICLE; DEBRIDEMENT; DEMOGRAPHY; DISEASE SEVERITY; FEMALE; FUNGUS; GRAM NEGATIVE BACTERIUM; HUMAN; HYPERBARIC OXYGEN; INSULIN INFUSION; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MORTALITY; MULTICENTER STUDY; NECROTIZING FASCIITIS; POSTOPERATIVE CARE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SOFT TISSUE INFECTION; SOFT TISSUE INJURY; STATISTICAL ANALYSIS; STREPTOCOCCUS; TREATMENT OUTCOME;

ADULT; AGE FACTORS; AGED; ANALYSIS OF VARIANCE; CHI-SQUARE DISTRIBUTION; CRITICAL CARE; FASCIITIS, NECROTIZING; FEMALE; HOSPITAL MORTALITY; HOSPITALS, UNIVERSITY; HUMANS; INCIDENCE; LOGISTIC MODELS; MALE; MEDICAL RECORDS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MIDDLE AGED; NECROSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SOFT TISSUE INFECTIONS; TEXAS; TREATMENT OUTCOME;

EID: 79960990852     PISSN: 00029610     EISSN: 18791883     Source Type: Journal    
DOI: 10.1016/j.amjsurg.2010.07.041     Document Type: Article

References (38)

1. Gunter OL, Guillamondegui OD, May AK, et al. Outcome of necrotizing skin and soft tissue infections. Surg Infect Larchmt 2008;9:443-50.
2. Endorf FW, Klein MB, Mack CD, et al. Necrotizing soft-tissue infections: differences in patients treated at burn centers and non-burn centers. J Burn Care Res 2008;29:933-8.
3. Anaya DA, Bulger EM, Kwon YS, et al. Predicting death in necrotizing soft tissue infections: a clinical score. Surg Infect Larchmt 2009;10:517-22.
4. Hsiao CT, Weng HH, Yuan YD, et al. Predictors of mortality in patients with necrotizing fasciitis. Am J Emerg Med 2008;26:170-5.
5. Light TD, Choi KC, Thomsen TA, et al. Long-term outcomes of patients with necrotizing fasciitis. J Burn Care Res 2010;31:93-9.
6. Anaya DA, McMahon K, Nathens AB, et al. Predictors of mortality and limb loss in necrotizing soft tissue infections. Arch Surg 2005;140:151-7. (Pubitemid 40229103)
7. McHenry CR, Piotrowski JJ, Petrinic D, et al. Determinants of mortality for necrotizing soft-tissue infections. Ann Surg 1995;221:558-63.
8. Pham TN, Moore ML, Costa BA, et al. Assessment of functional limitation after necrotizing soft tissue infection. J Burn Care Res 2009;30:301-6.
9. Dworkin MS, Westercamp MD, Park L, et al. The epidemiology of necrotizing fasciitis including factors associated with death and amputation. Epidemiol Infect 2009;137:1-6.
10. Golger A, Ching S, Goldsmith CH, et al. Mortality in patients with necrotizing fasciitis. Plast Reconstr Surg 2007;119:1803-7. (Pubitemid 46632066)
11. Mulla ZD, Gibbs SG, Aronoff DM. Correlates of length of stay, cost of care, and mortality among patients hospitalized for necrotizing fasciitis. Epidemiol Infect 2007;135:868-76. (Pubitemid 47161673)
12. Elliott DC, Kufera JA, Myers RA. Necrotizing soft tissue infections. Risk factors for mortality and strategies for management. Ann Surg 1996;224:672-83.
13. Malangoni MA. Necrotizing soft tissue infections: are we making any progress? Surg Infect Larchmt 2001;2:145-50.
14. Wong CH, Chang HC, Pasupathy S, et al. Necrotizing fasciitis: clinical presentation, microbiology, and determinants of mortality. J Bone Joint Surg Am 2003;85-A:1454-60. (Pubitemid 36951128)
15. Bair MJ, Chi H, Wang WS, et al. Necrotizing fasciitis in southeast Taiwan: clinical features, microbiology, and prognosis. Int J Infect Dis 2009;13:255-60.
16. Fagan SP, Berger DH, Rahwan K, et al. Spider bites presenting with methicillin-resistant Staphylococcus aureus soft tissue infection require early aggressive treatment. Surg Infect Larchmt 2003;4:311-5. (Pubitemid 38195780)
17. Miller LG, Perdreau-Remington F, Rieg G, et al. Necrotizing fasciitis caused by community-associated methicillin-resistant Staphylococcus aureus in Los Angeles. N Engl J Med 2005;352:1445-53. (Pubitemid 40471452)
18. Dunbar NM, Harruff RC. Necrotizing fasciitis: manifestations, microbiology and connection with black tar heroin. J Forensic Sci 2007;52:920-3. (Pubitemid 46918563)
19. Lee CC, Chi CH, Lee, et al. Necrotizing fasciitis in patients with liver cirrhosis: predominance of monomicrobial Gram-negative bacillary infections. Diagn Microbiol Infect Dis 2008;62:219-25.
20. Lee TC, Carrick MM, Scott BG, et al. Incidence and clinical characteristics of methicillin-resistant Staphylococcus aureus necrotizing fasciitis in a large urban hospital. Am J Surg 2007;194:809-12.
21. Levy MM, Fink MP, Marshall JC, et al. SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 2001;2003:1250-6.
22. Abraham E, Laterre PF, Garg R, et al. Drotrecogin alfa (activated) for adults with severe sepsis and a low risk of death. N Engl J Med 2005;353:1332-41. (Pubitemid 41362701)
23. Dellinger RP, Levy MM, Carlet JM, et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock. Crit Care Med 2008;36:296-327.
24. Leitch HA, Palepu A, Fernandes CM. Necrotizing fasciitis secondary to group A streptococcus. Morbidity and mortality still high. Can Fam Physician 2000;46:1460-6.
25. Yaghoubian A, de Virgilio C, Dauphine C, et al. Use of admission serum lactate and sodium levels to predict mortality in necrotizing soft-tissue infections. Arch Surg 2007;142:840-6.
26. Young LM, Price CS. Community-acquired methicillin-resistant Staphylococcus aureus emerging as an important cause of necrotizing fasciitis. Surg Infect Larchmt 2008;9:469-74.
27. Kowalski TJ, Berbari EF, Osmon DR. Epidemiology, treatment, and prevention of community-acquired methicillin-resistant Staphylococcus aureus infections. Mayo Clin Proc 2005;80:1201-7.
28. Bernard GR, Vincent JL, Laterre PF, et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001;344:699-709. (Pubitemid 32204987)
29. Purnell D, Hazlett T, Alexander SL. A new weapon against severe sepsis related to necrotizing fasciitis. Dimens Crit Care Nurs 2004;23:18-23.
30. Bland CM, Frizzi JD, Reyes A. Use of drotrecogin alfa in necrotizing fasciitis: a case report and pharmacologic review. J Intensive Care Med 2008;23:342-6.
31. Sarani B, Strong M, Pascual J, et al. Necrotizing fasciitis: current concepts and review of the literature. J Am Coll Surg 2009;208:279-88.
32. Yilmazlar T, Ozturk E, Alsoy A, et al. Necrotizing soft tissue infections: Apache II score, dissemination, and survival. World J Surg 2007;31:1858-6.
33. Su YC, Chen HW, Hong YC, et al. Laboratory risk indicator for necrotizing fasciitis score and the outcomes. ANZ J Surg 2008;78:968-72.
34. Wong CH, Khin LW, Heng KS, et al. (Laboratory Risk Indicator for Necrotizing Fasciitis) score: a tool for distinguishing necrotizing fasciitis from other soft tissue infections. Crit Care Med 2004;32:1535-41.
35. Brown DR, Davis NL, Lepawsky M, et al. A multicenter review of the treatment of major truncal necrotizing infections with and without hyperbaric oxygen therapy. Am J Surg 1994;167:485-9. (Pubitemid 24203529)
36. George ME, Rueth NM, Skarda DE, et al. Hyperbaric oxygen does not improve outcome in patients with necrotizing soft tissue infection. Surg Infect Larchmt 2009;10:21-8.
37. May AK, Stafford RE, Bulger EM, et al. Treatment of complicated skin and soft tissue infections. Surg Infect Larchmt 2009;10:467-99.
38. Endorf FW, Cancio LC, Klein MB. Necrotizing soft-tissue infections: clinical guidelines. J Burns Care Resour 2009;30:769-75.